KELSEY SCHERER: Open Payments
NPI 1750098752 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$404 in 19 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $113 · 2025 $404
Food & beverage: $404
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 6 | $110 |
| Madrigal Pharmaceuticals | 4 | $79 |
| Novo Nordisk Inc | 3 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $61 |
| Eisai Inc. | 1 | $30 |
| Intercept Pharmaceuticals, Inc. | 1 | $25 |
| ORPHALAN INC | 1 | $17 |
| Eurofins Viracor, LLC | 1 | $14 |
Products named: PREVYMIS, REZDIFFRA, Wegovy, LIVTENCITY, Lenvima, OCALIVA, CUVRIOR.
Industry payments across CA — which companies pay providers there.
